A retrospective evaluation of the clinical records of 138 depressed patients, who received the dexamethasone suppression test (DST) as part of a standardized physical and psychiatric assessment protocol, revealed that 60 had acute, chronic (mild or severe), stable or remitted medical conditions. The proportion of DST nonsuppressors did not differ between depressed subjects with medical conditions (45 % nonsuppressors) and those without (34.6% nonsuppressors; p > 0.2). However, all of the six subjects with acute or chronic-severe medical conditions were found to be nonsuppressors (p = 0.003). These results may help clarify the medical exclusion criteria for the clinical application of the DST.
References
1.
StokesP.E., StollP.M., KoslowS.H.Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups.Arch Gen Psychiatry1984; 41: 257–267.
2.
FichterM.M., PirkeK.M., HolsboerF.Weight loss causes neu-roendocrine disturbances: experimental study in healthy starving subjects.Psychiatry Res1986; 17: 61–72.
3.
AranaG.W., BaldessariniR.J., OrnsteenM.The dexamethasone suppression test for diagnosis and prognosis in psychiatry.Arch Gen Psychiatry1985; 42: 1193–1204.
4.
ShapiroM.F., LehmanA.F.The diagnosis of depression in different clinical settings: an analysis of the literature on the dexamethasone suppression test.J Nerv Ment Dis1983; 171: 714–720.
5.
GreenH.S., KaneJ.M.The dexamethasone suppression test in depression.Clin Neuropharmacol1983; 6: 7–24.
6.
RihmerZ., AratoM.The DST as a clinical research tool in patients with affective disorders.Psychopharmacol Bull1984; 20: 174–177.
7.
APA Task Force on Laboratory Tests in Psychiatry.The dexamethasone suppression test: an overview of its current status in psychiatry.Am J Psychiatry1987; 144: 1253–1262.
8.
CarrollB.J., FeinbergM., GredenJ.F.A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.Arch Gen Psychiatry1981; 38: 15–22.
9.
AnanthJ.Physical illness and psychiatric disorders.Compr Psychiatry1984; 25: 586–593.
10.
MontgomeryS.A., AsbergM.A new depression scale designed to be sensitive to change.Br J Psychiatry1979; 134: 382–389.
11.
FeighnerJ.P., RobinsE., GuzeS.B.Diagnostic criteria for use in psychiatric research.Arch Gen Psychiatry1972; 26: 57–63.
12.
HelzerJ.Renard Diagnostic Interview.St. Louis: Washington School of Medicine,1971.
13.
RobinsL., HelzerJ.E., CroughanJ.National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics and validity.Arch Gen Psychiatry1981; 38: 381–389.
14.
SpitzerR.L., EndicottJ., RobinsE.Research Diagnostic Criteria (RDC) for a selected group of functional disorders, 2 ed.New York: Biometrics Research Institute,1975.
15.
WongP.Y., MeeA.V., HoF.F.K.A direct radioimmunoassay of serum Cortisol with in-house 125I-tracer and preconjugated double antibody.Clin Chem1979; 25: 914–917.
16.
SnaithR.P., HarropF.M., NewbyD.A.Grade scores of the Montgomery-Asberg depression and the clinical anxiety scales.Br J Psychiatry1986; 148: 599–601.
17.
KrausR.P., GrofP., BrownG.M.Drugs and the DST: need for a reappraisal.Am J Psychiatry1988; 145: 666–674.
18.
PavlatosF., SmiloR.P., ForshamP.H.A rapid screening test for Cushing's syndrome.JAMA1965; 193: 720–723.
19.
ConnollyC.K., GoreM.B.R., StanleyN.Single dose dexamethasone suppression in normal subjects and hospital patients.Br Med J1968; 2: 665–667.
WallaceE.Z., RosmanP., ToshavN.Pituitary-adrenocortical function in chronic renal failure: studies of episodic secretion of Cortisol and dexamethasone suppressibility.J Clin Endocrinol Met1980; 50: 46–51.
22.
McHardy-YoungS., HarrisP.W.R., LessofM.H.Single-dose dexamethasone suppression test for Cushing's syndrome.Br Med J1967; 2: 740–744.
23.
CarnesM., SmithJ.C., KalinN.H.Effects of chronic medical illness and dementia on the dexamethasone suppression test.J Am Geriatr Soc1983; 31: 269–271.
24.
FranceR.D., KrishnanR.R., HouptJ.L.Differentiation of depression from chronic pain with the dexamethasone suppression test and DSM-III.Am J Psychiatry1985; 141: 1577–1578.
25.
SyvalahtiE., HyyppaM.T., SalminenJ.K.Depression and the dexamethasone suppression test (DST) in patients with nonspecific somatic complaints.Ann Clin Res1985; 17: 148–151.
26.
FavaG.A., TrombiniG., BarbaraL.Depression and gas-trointestinal illness: the joint use of biological and clinical criteria.Am J Gastroenterol1985; 80: 195–199.
27.
FinkelsteinS., BenowitzL.I., BaldessariniR.J.Mood, vegetative disturbance, and dexamethasone suppression test after stroke.Ann Neurol1982; 12: 463.
28.
LipseyJ.R., RobinsonR.G., PearisonG.D.The dexamethasone suppression test and mood following stroke.Am J Psychiatry1985; 142: 318–323.
29.
SparJ.E., GernerR.Does the dexamethasone suppression test distinguish dementia from depression?Am J Psychiatry1982; 139: 238–239.
30.
RaskindM., PeskindE., RivardM.F.Dexamethasone suppression test and Cortisol circadian rhythm in primary degenerative dementia.Am J Psychiatry1982; 139: 1468–1471.
31.
BalldinJ., GottfriesC.G., KarlssonI.Dexamethasone suppression test and serum prolactin in dementia disorders.Br J Psychiatry1983; 143: 277–281.
32.
GeorgotasA., McCueR.E., KimO.M.Dexamethasone suppression in dementia, depression and normal aging.Am J Psychiatry1986; 143: 452–456.
33.
CarnesM., SmithJ.C., KalinN.H.The dexamethasone suppression test in demented outpatients with and without depression.Psychiatry Res1983; 9: 337–343.
